Literature DB >> 32411499

Case report; meta-synchronous triple malignancy in primary diagnosed CML patient.

Esraa Jamal1, Shaimaa El-Ashwah1, Mohamed A Ebrahim2, Marwa Ma Zaki3, Layla'M Saleh4, Adel El-Badrawy5, Emad Azmy1.   

Abstract

The diagnosis of different types of cancer in a single patient has been appeared in the field in some case reports involving different categories of cancer types either appeared at the same time (synchronous) or subsequently (meta-synchronous). The aim of this report is to present this interesting case of male patient who was under treatment of CML then T-lymphoblastic lymphoma and HCC discovered subsequently. CML, Lymphoma and HCC are arising from different lines of cells with different biology and cytogenetic criteria. CML and acute lymphoblastic leukemia may occur together in cases of blastic crisis of CML. But, they rarely occur together as separate multiple malignancies especially without any history of exposure to ionizing radiation, chemotherapy or transplantation. AJBR
Copyright © 2020.

Entities:  

Keywords:  Chronic myeloid leukemia; T-lymphoblastic lymphoma; hepatitis C virus; hepatocellular carcinoma; tyrosine kinase inhibitor

Year:  2020        PMID: 32411499      PMCID: PMC7218681     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  9 in total

Review 1.  [Haploidentical hematopoietic stem cell transplantation for treatment of T-lymphoblastic lymphoma with chronic myeloid leukemia: a case report and literature review].

Authors:  Ding-ming Wan; Su-ping Zhang; Cheng Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2012-03

2.  Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

Authors:  Koji Sasaki; Hagop M Kantarjian; Susan O'Brien; Farhad Ravandi; Marina Konopleva; Gautam Borthakur; Guillermo Garcia-Manero; William G Wierda; Naval Daver; Alessandra Ferrajoli; Koichi Takahashi; Preetesh Jain; Mary Beth Rios; Sherry A Pierce; Elias J Jabbour; Jorge E Cortes
Journal:  Int J Hematol       Date:  2019-03-04       Impact factor: 2.490

Review 3.  Possible association between adult T-cell leukemia/lymphoma and acute myeloid leukemia.

Authors:  K Tsukasaki; T Koba; M Iwanaga; K Murata; T Maeda; S Atogami; H Nakamura; Y Yamada; S Kamihira; M Tomonaga
Journal:  Cancer       Date:  1998-02-01       Impact factor: 6.860

4.  Concomitant hepatocellular carcinoma and non-Hodgkin's lymphoma in a patient with nodular regenerative hyperplasia.

Authors:  Tatsuki R Kataoka; Yoshitane Tsukamoto; Naoko Kanazawa; Tadahiro Izumi; Nobuhisa Awata; Yasuko Nishizawa; Masahiko Ohsawa; Shingo Ishiguro
Journal:  Pathol Int       Date:  2006-05       Impact factor: 2.534

5.  Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.

Authors:  Hung Chang; Wen-Yu Chuang; Chien-Feng Sun; Marc R Barnard
Journal:  Diagn Pathol       Date:  2012-02-22       Impact factor: 2.644

6.  Philadelphia chromosome-negative non-Hodgkin's lymphoma occurring in Philadelphia chromosome-positive chronic myeloid leukemia: A case report and literature review.

Authors:  Zheng-Lei Shen; Lie-Fen Yin; Wen-Wen Mao; Jin Liang; Ling Yang
Journal:  Oncol Lett       Date:  2016-03-07       Impact factor: 2.967

Review 7.  Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia.

Authors:  Guoqing Wei; Jiasheng Wang; He Huang; Yanmin Zhao
Journal:  J Hematol Oncol       Date:  2017-08-18       Impact factor: 17.388

8.  Analyses and treatment of simultaneous bi-lineage malignancies of myeloid leukemia and lymphoma: Two case reports and a literature review.

Authors:  Xiaorui Fu; Yufeng Shang; Lei Zhang; Ling Li; Xin Li; Xinhua Wang; Zhenchang Sun; Mingzhi Zhang
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

9.  An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States.

Authors:  Vivek Kumar; Mohit Garg; Neha Chaudhary; Abhinav Binod Chandra
Journal:  PeerJ       Date:  2018-02-12       Impact factor: 2.984

  9 in total
  1 in total

1.  Atypical presentation of patients with chronic myeloid leukemia in chronic phase-Case report.

Authors:  Florian Ramdohr; Alice Fabarius; Bettina Maier; Daniela Bretschneider; Anna Jauch; Astrid Monecke; Klaus H Metzeler; Johannes W G Janssen; Richard F Schlenk; Sabine Kayser
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.